clobetasone butyrate has been researched along with fluocinolone acetonide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Forster, S; Ilderton, E; Norris, JF; Summerly, R; Yardley, HJ | 1 |
Di Nardo, A; Giannetti, A; Seidenari, S | 1 |
3 other study(ies) available for clobetasone butyrate and fluocinolone acetonide
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone Valerate; Clobetasol; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydrocortisone; Phospholipases; Phospholipases A; Phospholipases A2; Psoriasis; Skin; Time Factors | 1984 |
Assessment of topical corticosteroid activity on experimentally induced contact dermatitis: echographic evaluation with binary transformation and image analysis.
Topics: Administration, Topical; Adult; Clobetasol; Dermatitis, Contact; Female; Fluocinolone Acetonide; Humans; Image Enhancement; Skin; Ultrasonography | 1993 |